Search research articles
Contact Us
Filters
Showing results (21-30 of 143) with videos related to
Page
of 15
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 30, 2007
Blood pressure--the better biomarker: delay in clinical application
Thomas D Giles
The American Journal of Medicine
|
June 7, 2002
Atherosclerotic cardiovascular disease: new approaches to risk assessment and intervention. Introduction
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 9, 2011
It is all about flow or, why there will never be one optimal blood pressure goal for every patient with hypertension
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 20, 2010
Great expectations fulfilled
Thomas D Giles
Postgraduate Medicine
|
August 12, 2009
Use of beta-blockers for heart failure in patients with diabetes mellitus
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 16, 2009
Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence
Thomas D Giles
Reviews in Cardiovascular Medicine
|
April 3, 2007
Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy
Thomas D Giles
The American Journal of Medicine
|
July 9, 2010
The beta-blockers are among the more heterogeneous classes of drugs in terms of mechanism of action and pharmacodynamic action. Introduction
Thomas D Giles
Current Cardiology Reports
|
October 25, 2006
Should we redefine hypertension?
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 17, 2009
A new speciality is being born
Thomas D Giles
Page
of 15
Search research articles
Search
Showing results (21-30 of 143) with videos related to
Sort By:
Page
of 15
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 30, 2007
Blood pressure--the better biomarker: delay in clinical application
Thomas D Giles
The American Journal of Medicine
|
June 7, 2002
Atherosclerotic cardiovascular disease: new approaches to risk assessment and intervention. Introduction
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 9, 2011
It is all about flow or, why there will never be one optimal blood pressure goal for every patient with hypertension
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 20, 2010
Great expectations fulfilled
Thomas D Giles
Postgraduate Medicine
|
August 12, 2009
Use of beta-blockers for heart failure in patients with diabetes mellitus
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 16, 2009
Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence
Thomas D Giles
Reviews in Cardiovascular Medicine
|
April 3, 2007
Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy
Thomas D Giles
The American Journal of Medicine
|
July 9, 2010
The beta-blockers are among the more heterogeneous classes of drugs in terms of mechanism of action and pharmacodynamic action. Introduction
Thomas D Giles
Current Cardiology Reports
|
October 25, 2006
Should we redefine hypertension?
Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 17, 2009
A new speciality is being born
Thomas D Giles
Page
of 15